Author: Ignacio-Ibarra, Gregorio; GarcÃa-Lee, Ma Teresa; González-Ãvila, Ana I; GarcÃa-Chávez, Jaime; Guzmán-Chores, Laura; Cruz, Cindy Ledesma-de la; Lugo-GarcÃa, Yolanda; Juárez-Lara, Jessi; GarcÃa-Vázquez, Mauricio; Madera-Maldonado, Cristina E; Ramos-Peñafiel, Christian O; Majluf-Cruz, Abraham
Title: A proposal for the management of COVID-19-induced coagulopathy in adults. Cord-id: zzc4bxfj Document date: 2021_1_1
ID: zzc4bxfj
Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is the cause of the coronavirus disease 2019 (COVID-19) pandemic, which has a high case fatality rate. Most severely ill patients develop a special type of coagulopathy that had not been described before and that is now considered the main cause of death. For this reason, anticoagulant treatment has become one of the cornerstones of the treatment of this infection. However, the rate at which the evidence regarding the use of
Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is the cause of the coronavirus disease 2019 (COVID-19) pandemic, which has a high case fatality rate. Most severely ill patients develop a special type of coagulopathy that had not been described before and that is now considered the main cause of death. For this reason, anticoagulant treatment has become one of the cornerstones of the treatment of this infection. However, the rate at which the evidence regarding the use of anticoagulants is generated is quite fast, and sometimes it is difficult to interpret and conflicting. After having performed an extensive review of the published literature, this proposal for the use of anticoagulant treatment is made, taking into account available resources in Mexico.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date